252.15(2)(a)7.d.
d. The court is not required to order the individual to submit to a test under
subd. 7. c. if the court finds substantial reason relating to the life or health of the individual not to do so and states the reason on the record.
252.15(2)(a)7m.
7m. The test results of an individual under
subd. 7. may be disclosed only to the individual, if he or she so consents, to anyone authorized by the individual and to the affected person who was certified to have been significantly exposed. A record may be retained of the test results only if the record does not reveal the individual's identity. If the affected person knows the identity of the individual whose blood was tested, he or she may not disclose the identity to any other person except for the purpose of having the test or series of tests performed.
252.15(2)(am)1.1. A health care provider who procures, processes, distributes or uses human sperm donated as specified under
s. 157.06 (6) (a) or
(b) shall, prior to the distribution or use and with informed consent under the requirements of
par. (b), test the proposed donor for the presence of HIV, antigen or nonantigenic products of HIV or an antibody to HIV in order to assure medical acceptability of the gift for the purpose intended. The health care provider shall use as a test for the presence of HIV, antigen or nonantigenic products of HIV or an antibody to HIV a test or series of tests that the state epidemiologist finds medically significant and sufficiently reliable under
s. 252.13 (1r) to detect the presence of HIV, antigen or nonantigenic products of HIV or an antibody to HIV. The health care provider shall test the donor initially and, if the initial test result is negative, shall perform a 2nd test on a date that is not less than 180 days from the date of the procurement of the sperm. No person may use the donated sperm until the health care provider has obtained the results of the 2nd test. If any validated test result of the donor for the presence of HIV, antigen or nonantigenic products of HIV or an antibody to HIV is positive, the sperm donated for use may not be used and, if donated, shall be destroyed.
252.15(2)(am)2.a.a. A health care provider who procures, processes, distributes or uses human ova donated as specified under
s. 157.06 (6) (a) or
(b) shall, prior to the distribution or use and with informed consent under the requirements of
par. (b), test the proposed donor for the presence of HIV, antigen or nonantigenic products of HIV or an antibody to HIV in order to assure medical acceptability of the gift for the purpose intended, only if the state epidemiologist finds that use of donated human ova provides a significant risk of transmitting HIV to a donee and if, notwithstanding
ss. 227.01 (13) and
227.10 (1), the secretary of health and family services issues an order specifying the requirements for the testing.
252.15(2)(b)
(b) The health care provider, blood bank, blood center or plasma center that subjects a person to a test for the presence of HIV, antigen or nonantigenic products of HIV or an antibody to HIV under
pars. (a) and
(am) shall, in instances under those paragraphs in which consent is required, provide the potential test subject with an informed consent form for testing or disclosure that shall contain the following information and on the form shall obtain the potential test subject's signature or may, if the potential test subject has executed a power of attorney for health care instrument under
ch. 155 and has been found to be incapacitated under
s. 155.05 (2), instead obtain the signature of the health care agent:
252.15(2)(b)1.
1. The name of the potential test subject who is giving consent and whose test results may be disclosed and, if the potential test subject has executed a power of attorney for health care instrument under
ch. 155 and has been found to be incapacitated under
s. 155.05 (2), the name of the health care agent.
252.15(2)(b)2.
2. A statement of explanation to the potential test subject that the test results may be disclosed as specified under
sub. (5) (a) and either a listing that duplicates the persons or circumstances specified under
sub. (5) (a) 2. to
19. or a statement that the listing is available upon request.
252.15(2)(b)3.
3. Spaces specifically designated for the following purposes:
252.15(2)(b)3.a.
a. The signature of the potential test subject or, if the potential test subject has executed a power of attorney for health care instrument under
ch. 155 and has been found to be incapacitated under
s. 155.05 (2), of the health care agent, providing informed consent for the testing and the date on which the consent is signed.
252.15(2)(b)3.b.
b. The name of a person to whom the potential test subject or, if the potential test subject has executed a power of attorney for health care instrument under
ch. 155 and has been found to be incapacitated under
s. 155.05 (2), the health care agent, authorizes that disclosure of test results be made, if any, the date on which the consent to disclosure is signed, and the time period during which the consent to disclosure is effective.
252.15(2)(bm)
(bm) The health care provider that subjects a person to a test for the presence of HIV, antigen or nonantigenic products of HIV or an antibody to HIV under
par. (a) 3. shall provide the test subject and the test subject's guardian, if the test subject is incompetent under
ch. 880, with all of the following information:
252.15(2)(bm)1.
1. A statement of explanation concerning the test that was performed, the date of performance of the test and the test results.
252.15(2)(bm)2.
2. A statement of explanation that the test results may be disclosed as specified under
sub. (5) (a) and either a listing that duplicates the persons or circumstances specified under
sub. (5) (a) 2. to
18. or a statement that the listing is available upon request.
252.15(3)
(3) Written consent to disclosure. A person who receives a test for the presence of HIV, antigen or nonantigenic products of HIV or an antibody to HIV under
sub. (2) (b) or, if the person has executed a power of attorney for health care instrument under
ch. 155 and has been found to be incapacitated under
s. 155.05 (2), the health care agent may authorize in writing a health care provider, blood bank, blood center or plasma center to disclose the person's test results to anyone at any time subsequent to providing informed consent for disclosure under
sub. (2) (b) and a record of this consent shall be maintained by the health care provider, blood bank, blood center or plasma center so authorized.
252.15(4)
(4) Record maintenance. A health care provider, blood bank, blood center or plasma center that obtains from a person a specimen of body fluids or tissues for the purpose of testing for the presence of HIV, antigen or nonantigenic products of HIV or an antibody to HIV shall:
252.15(4)(a)
(a) Obtain from the subject informed consent for testing or disclosure, as provided under
sub. (2).
252.15(4)(c)
(c) Maintain a record of the test results obtained. A record that is made under the circumstances described in
sub. (2) (a) 7m. may not reveal the identity of the test subject.
252.15(5)(a)(a) An individual who is the subject of a test for the presence of HIV, antigen or nonantigenic products of HIV or an antibody to HIV or the individual's health care agent, if the individual has executed a power of attorney for health care instrument under
ch. 155 and has been found to be incapacitated under
s. 155.05 (2), may disclose the results of the individual's test to anyone. A person who is neither the individual nor the individual's health care agent may not, unless he or she is specifically authorized by the individual to do so, disclose the individual's test results except to the following persons or under the following circumstances:
252.15(5)(a)1.
1. To the subject of the test and, if the test subject has executed a power of attorney for health care instrument under
ch. 155 and has been found to be incapacitated under
s. 155.05 (2), the health care agent.
252.15(5)(a)2.
2. To a health care provider who provides care to the test subject, including those instances in which a health care provider provides emergency care to the subject.
252.15(5)(a)3.
3. To an agent or employe of a health care provider under
subd. 2. who prepares or stores patient health care records, as defined in
s. 146.81 (4), for the purposes of preparation or storage of those records; provides patient care; or handles or processes specimens of body fluids or tissues.
252.15(5)(a)4.
4. To a blood bank, blood center or plasma center that subjects a person to a test under
sub. (2) (a), for any of the following purposes:
252.15(5)(a)4.a.
a. Determining the medical acceptability of blood or plasma secured from the test subject.
252.15(5)(a)5.
5. To a health care provider who procures, processes, distributes or uses a human body part donated as specified under
s. 157.06 (6) (a) or
(b), for the purpose of assuring medical acceptability of the gift for the purpose intended.
252.15(5)(a)6.
6. To the state epidemiologist or his or her designee, for the purpose of providing epidemiologic surveillance or investigation or control of communicable disease.
252.15(5)(a)7.
7. To a funeral director, as defined under
s. 445.01 (5) or to other persons who prepare the body of a decedent for burial or other disposition or to a person who performs an autopsy or assists in performing an autopsy.
252.15(5)(a)8.
8. To health care facility staff committees or accreditation or health care services review organizations for the purposes of conducting program monitoring and evaluation and health care services reviews.
252.15(5)(a)10.
10. To a person who conducts research, for the purpose of research, if the researcher:
252.15(5)(a)10.b.
b. Has obtained permission to perform the research from an institutional review board.
252.15(5)(a)10.c.
c. Provides written assurance to the person disclosing the test results that use of the information requested is only for the purpose under which it is provided to the researcher, the information will not be released to a person not connected with the study, and the final research product will not reveal information that may identify the test subject unless the researcher has first received informed consent for disclosure from the test subject.
252.15(5)(a)11.
11. To a person, including a person exempted from civil liability under the conditions specified under
s. 895.48, who renders to the victim of an emergency or accident emergency care during the course of which the emergency caregiver is significantly exposed to the emergency or accident victim, if a physician, based on information provided to the physician, determines and certifies in writing that the emergency caregiver has been significantly exposed and if the certification accompanies the request for disclosure.
252.15(5)(a)12.
12. To a coroner, medical examiner or an appointed assistant to a coroner or medical examiner, if one or more of the following conditions exist:
252.15(5)(a)12.a.
a. The possible HIV-infected status is relevant to the cause of death of a person whose death is under direct investigation by the coroner, medical examiner or appointed assistant.
252.15(5)(a)12.b.
b. The coroner, medical examiner or appointed assistant is significantly exposed to a person whose death is under direct investigation by the coroner, medical examiner or appointed assistant, if a physician, based on information provided to the physician, determines and certifies in writing that the coroner, medical examiner or appointed assistant has been significantly exposed and if the certification accompanies the request for disclosure.
252.15(5)(a)13.
13. To a sheriff, jailer or keeper of a prison, jail or house of correction or a person designated with custodial authority by the sheriff, jailer or keeper, for whom disclosure is necessitated in order to permit the assigning of a private cell to a prisoner who has a positive test result.
252.15(5)(a)14.
14. If the test results of a test administered to an individual are positive and the individual is deceased, by the individual's attending physician, to persons, if known to the physician, with whom the individual has had sexual contact or has shared intravenous drug use paraphernalia.
252.15(5)(a)15.
15. To anyone who provides consent for the testing under
sub. (2) (a) 4. b., except that disclosure may be made under this subdivision only during a period in which the test subject is adjudicated incompetent under
ch. 880, is under 14 years of age or is unable to communicate due to a medical condition.
252.15(5)(a)17.
17. To an alleged victim or victim, to a health care professional, upon request as specified in
s. 938.296 (4) (e) or
968.38 (4) (c), who provides care to the alleged victim or victim and, if the alleged victim or victim is a minor, to the parent or guardian of the alleged victim or victim, under
s. 938.296 (4) or
968.38 (4).
252.15(5)(a)19.
19. If the test was administered to a child who has been placed in a foster home, treatment foster home, group home, child caring institution or secured correctional facility, as defined in
s. 938.02 (15m), including a placement under
s. 48.205,
48.21,
938.205 or
938.21 or for whom placement in a foster home, treatment foster home, group home, child caring institution or secured correctional facility is recommended under
s. 48.33 (4),
48.425 (1) (g),
48.837 (4) (c) or
938.33 (3) or
(4), to an agency directed by a court to prepare a court report under
s. 48.33 (1),
48.424 (4) (b),
48.425 (3),
48.831 (2),
48.837 (4) (c) or
938.33 (1), to an agency responsible for preparing a court report under
s. 48.365 (2g),
48.425 (1),
48.831 (2),
48.837 (4) (c) or
938.365 (2g), to an agency responsible for preparing a permanency plan under
s. 48.355 (2e),
48.38,
48.43 (1) (c) or
(5) (c),
48.63 (4),
48.831 (4) (e),
938.355 (2e) or
938.38 regarding the child or to an agency that placed the child or arranged for the placement of the child in any of those placements and, by any of those agencies, to any other of those agencies and, by the agency that placed the child or arranged for the placement of the child in any of those placements, to the child's foster parent or treatment foster parent or the operator of the group home, child caring institution or secured correctional facility in which the child is placed, as provided in
s. 48.371 or
938.371.
252.15(5)(b)
(b) A private pay patient may deny access to disclosure of his or her test results granted under
par. (a) 10. if he or she annually submits to the maintainer of his or her test results under
sub. (4) (c) a signed, written request that denial be made.
252.15(5m)
(5m) Autopsies; testing of certain corpses. Notwithstanding
s. 157.05, a corpse may be subjected to a test for the presence of HIV, antigen or nonantigenic products of HIV or an antibody to HIV and the test results disclosed to the person who has been significantly exposed under any of the following conditions:
252.15(5m)(a)
(a) If a person, including a person exempted from civil liability under the conditions specified under
s. 895.48, who renders to the victim of an emergency or accident emergency care during the course of which the emergency caregiver is significantly exposed to the emergency or accident victim and the emergency or accident victim subsequently dies prior to testing for the presence of HIV, antigen or nonantigenic products of HIV or an antibody to HIV, and if a physician, based on information provided to the physician, determines and certifies in writing that the emergency caregiver has been significantly exposed and if the certification accompanies the request for testing and disclosure. Testing of a corpse under this paragraph shall be ordered by the coroner, medical examiner or physician who certifies the victim's cause of death under
s. 69.18 (2) (b),
(c) or
(d).
252.15(5m)(b)
(b) If a funeral director, coroner, medical examiner or appointed assistant to a coroner or medical examiner who prepares the corpse of a decedent for burial or other disposition or a person who performs an autopsy or assists in performing an autopsy is significantly exposed to the corpse, and if a physician, based on information provided to the physician, determines and certifies in writing that the funeral director, coroner, medical examiner or appointed assistant has been significantly exposed and if the certification accompanies the request for testing and disclosure. Testing of a corpse under this paragraph shall be ordered by the attending physician of the funeral director, coroner, medical examiner or appointed assistant who is so exposed.
252.15(5m)(c)
(c) If a health care provider or an agent or employe of a health care provider is significantly exposed to the corpse or to a patient who dies subsequent to the exposure and prior to testing for the presence of HIV, antigen or nonantigenic products of HIV or an antibody to HIV, and if a physician who is not the health care provider, based on information provided to the physician, determines and certifies in writing that the health care provider, agent or employe has been significantly exposed and if the certification accompanies the request for testing and disclosure. Testing of a corpse under this paragraph shall be ordered by the physician who certifies that the significant exposure has occurred.
252.15(5r)
(5r) Sale of tests without approval prohibited. No person may sell or offer to sell in this state a test or test kit to detect the presence of HIV, antigen or nonantigenic products of HIV or an antibody to HIV for self-use by an individual unless the test or test kit is first approved by the state epidemiologist. In reviewing a test or test kit under this subsection, the state epidemiologist shall consider and weigh the benefits, if any, to the public health of the test or test kit against the risks, if any, to the public health of the test or test kit.
252.15(6)
(6) Expanded disclosure of test results prohibited. No person to whom the results of a test for the presence of HIV, antigen or nonantigenic products of HIV or an antibody to HIV have been disclosed under
sub. (5) (a) or
(5m) may disclose the test results except as authorized under
sub. (5) (a) or
(5m).
252.15(7)
(7) Reporting of positive test results. 252.15(7)(a)(a) Notwithstanding
ss. 227.01 (13) and
227.10 (1), for the purposes of this subsection, the state epidemiologist shall determine, based on the preponderance of available scientific evidence, the procedures necessary in this state to obtain a validated test result and the secretary shall so declare under
s. 250.04 (1) or
(2) (a). The state epidemiologist shall revise this determination if, in his or her opinion, changed available scientific evidence warrants a revision, and the secretary shall declare the revision under
s. 250.04 (1) or
(2) (a).
252.15(7)(b)
(b) If a positive, validated test result is obtained from a test subject, the health care provider, blood bank, blood center or plasma center that maintains a record of the test results under
sub. (4) (c) shall report to the state epidemiologist the following information:
252.15(7)(b)1.
1. The name and address of the health care provider, blood bank, blood center or plasma center reporting.
252.15(7)(b)2.
2. The name and address of the subject's health care provider, if known.
252.15(7)(b)3.
3. The name, address, telephone number, age or date of birth, race and ethnicity, sex and county of residence of the test subject, if known.
252.15(7)(b)6.
6. Any other medical or epidemiological information required by the state epidemiologist for the purpose of exercising surveillance, control and prevention of HIV infections.
252.15(7)(c)
(c) Except as provided in
sub. (7m), a report made under
par. (b) may not include any of the following:
252.15(7)(c)1.
1. Information with respect to the sexual orientation of the test subject.
252.15(7)(c)2.
2. The identity of persons with whom the test subject may have had sexual contact.
252.15(7)(d)
(d) This subsection does not apply to the reporting of information under
s. 252.05 with respect to persons for whom a diagnosis of acquired immunodeficiency syndrome has been made.
252.15(7m)
(7m) Reporting of persons significantly exposed. If a positive, validated test result is obtained from a test subject, the test subject's physician who maintains a record of the test result under
sub. (4) (c) may report to the state epidemiologist the name of any person known to the physician to have been significantly exposed to the test subject, only after the physician has done all of the following:
252.15(7m)(a)
(a) Counseled the test subject to inform any person who has been significantly exposed to the test subject.
252.15(7m)(b)
(b) Notified the test subject that the name of any person known to the physician to have been significantly exposed to the test subject will be reported to the state epidemiologist.
252.15(8)(a)(a) Any person violating
sub. (2),
(5) (a),
(5m),
(6) or
(7) (c) is liable to the subject of the test for actual damages and costs, plus exemplary damages of up to $1,000 for a negligent violation and up to $5,000 for an intentional violation.
252.15(9)
(9) Criminal penalty. Whoever intentionally discloses the results of a blood test in violation of
sub. (2) (a) 7m.,
(5) (a) or
(5m) and thereby causes bodily harm or psychological harm to the subject of the test may be fined not more than $10,000 or imprisoned not more than 9 months or both.
252.15 History
History: 1985 a. 29,
73,
120;
1987 a. 70 ss.
13 to
27,
36;
1987 a. 403 ss.
136,
256;
1989 a. 200;
1989 a. 201 ss.
11 to
25,
36;
1989 a. 298,
359;
1991 a. 269;
1993 a. 16 s.
2567;
1993 a. 27 ss.
332,
334,
337,
340,
342; Stats. 1993 s. 252.15;
1993 a. 32,
183,
190,
252,
395,
491;
1995 a. 27 ss.
6323,
9116 (5),
9126 (19);
1995 a. 77,
275;
1997 a. 54,
80,
156,
188.
252.15 Annotation
No claim for violation of (2) was stated where the defendants neither conducted HIV tests nor were authorized recipients of the test results. Hillman v. Columbia County, 164 W (2d) 376, 474 NW (2d) 913 (Ct. App. 1991).
252.15 Annotation
This section does not prevent a court acting in equity from ordering an HIV test where this section does not apply. Syring v. Tucker, 174 W (2d) 787, 498 NW (2d) 370 (1993).
252.15 Annotation
Confidentiality of Medical Records. Meili. Wis. Law. Feb. 1995.
252.16
252.16
Health insurance premium subsidies. 252.16(1)(ar)
(ar) "Dependent" has the meaning given in
s. 635.02 (3c).
252.16 Note
NOTE: Section 635.02 (3c) was repealed.
252.16(1)(b)
(b) "Group health plan" means an insurance policy or a partially or wholly uninsured plan or program, that provides hospital, medical or other health coverage to members of a group, whether or not dependents of the members are also covered. The term includes a medicare supplement policy, as defined in
s. 600.03 (28r), but does not include a medicare replacement policy, as defined in
s. 600.03 (28p), or a long-term care insurance policy, as defined in
s. 600.03 (28g).
252.16(1)(c)
(c) "Individual health policy" means an insurance policy or a partially or wholly uninsured plan or program, that provides hospital, medical or other health coverage to an individual on an individual basis and not as a member of a group, whether or not dependents of the individual are also covered. The term includes a medicare supplement policy, as defined in
s. 600.03 (28r), but does not include a medicare replacement policy, as defined in
s. 600.03 (28p), or a long-term care insurance policy, as defined in
s. 600.03 (28g).
252.16(1)(e)
(e) "Residence" means the concurrence of physical presence with intent to remain in a place of fixed habitation. Physical presence is prima facie evidence of intent to remain.
252.16(2)
(2) Subsidy program. From the appropriation under
s. 20.435 (5) (am), the department shall distribute funding in each fiscal year to subsidize the premium costs under
s. 252.17 (2) and, under this subsection, the premium costs for health insurance coverage available to an individual who has HIV infection and who is unable to continue his or her employment or must reduce his or her hours because of an illness or medical condition arising from or related to HIV infection.
